HIGHLIGHTS
- who: DLX et al. from the Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Molecular Targeted Drugs, Beijing, China have published the research work: DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis, in the Journal: Disease Markers of 21/Oct/2022
- what: The authors explored the differentially expressed genes (DEGs) that were simultaneously correlated with four pathways (i.e. CD8+u03b1u03b2T cell proliferation/differentiation/activation pathways and ferroptosis pathway) and possibly to the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.